Highview Capital Management LLC Eli Lilly & CO Transaction History

Highview Capital Management LLC

$255 Million
Q4 2024

A detailed history of Highview Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Highview Capital Management LLC holds 7,071 shares of LLY stock, worth $6.15 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

7,071

Previous 6,763 4.55%

Holding current value

$6.15 Million

Previous $5.99 Million 8.9%

% of portfolio

2.14%

Previous 2.47%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$727.2 - $932.06 $223,977 - $287,074	308 Added 4.55%	7,071 $5.46 Million
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $139,757 - $173,763	181 Added 2.75%	6,763 $5.99 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $52,915 - $66,359	73 Added 1.12%	6,582 $5.96 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $119,032 - $159,248	-201 Reduced 3.0%	6,509 $5.06 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $163,334 - $192,549	311 Added 4.86%	6,710 $3.91 Million
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $29,994 - $41,351	-69 Reduced 1.07%	6,399 $3.44 Million
Q2 2023 Jul 19, 2023	BUY	$350.74 - $468.98 $7,365 - $9,848	21 Added 0.33%	6,468 $3.03 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $694,568 - $815,737	-2,236 Reduced 25.75%	6,447 $2.21 Million
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $67,525 - $78,680	210 Added 2.48%	8,683 $3.18 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $211,093 - $240,563	712 Added 9.17%	8,473 $2.74 Million
Q2 2022 Jul 25, 2022	SELL	$278.73 - $327.27 $143,545 - $168,544	-515 Reduced 6.22%	7,761 $2.52 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $564,429 - $701,442	2,405 Added 40.96%	8,276 $2.37 Million
Q4 2021 Jan 28, 2022	BUY	$224.85 - $279.04 $1.32 Million - $1.64 Million	5,871 New	5,871 $1.62 Million

Others Institutions Holding LLY

# of Institutions

4,104

Shares Held

743M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $827B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highview Capital Management LLC with notifications on news.

Account

Highview Capital Management LLC Eli Lilly & CO Transaction History